These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The human thyrotropin (TSH) receptor in a TSH binding inhibition assay for TSH receptor autoantibodies. Kakinuma A; Chazenbalk GD; Jaume JC; Rapoport B; McLachlan SM J Clin Endocrinol Metab; 1997 Jul; 82(7):2129-34. PubMed ID: 9215283 [TBL] [Abstract][Full Text] [Related]
24. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease. Kohn LD; Suzuki K; Hoffman WH; Tombaccini D; Marcocci C; Shimojo N; Watanabe Y; Amino N; Cho BY; Kohno Y; Hirai A; Tahara K J Clin Endocrinol Metab; 1997 Dec; 82(12):3998-4009. PubMed ID: 9398703 [TBL] [Abstract][Full Text] [Related]
25. Binding characteristics of antibodies to the TSH receptor. Oda Y; Sanders J; Roberts S; Maruyama M; Kato R; Perez M; Petersen VB; Wedlock N; Furmaniak J; Rees Smith B J Mol Endocrinol; 1998 Apr; 20(2):233-44. PubMed ID: 9584838 [TBL] [Abstract][Full Text] [Related]
26. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy. Kung AW; Lau KS; Kohn LD Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257 [TBL] [Abstract][Full Text] [Related]
27. Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into its inverse agonist and antagonist properties. Chen CR; McLachlan SM; Rapoport B Endocrinology; 2008 Jul; 149(7):3427-34. PubMed ID: 18388191 [TBL] [Abstract][Full Text] [Related]
28. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation. Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757 [TBL] [Abstract][Full Text] [Related]
29. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease. Lenzner C; Morgenthaler NG Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037 [TBL] [Abstract][Full Text] [Related]
30. Epitope analysis of the human thyrotropin (TSH) receptor using monoclonal antibodies. Oda Y; Sanders J; Evans M; Kiddie A; Munkley A; James C; Richards T; Wills J; Furmaniak J; Smith BR Thyroid; 2000 Dec; 10(12):1051-9. PubMed ID: 11201849 [TBL] [Abstract][Full Text] [Related]
31. A new assay for thyrotropin receptor autoantibodies. Smith BR; Bolton J; Young S; Collyer A; Weeden A; Bradbury J; Weightman D; Perros P; Sanders J; Furmaniak J Thyroid; 2004 Oct; 14(10):830-5. PubMed ID: 15588379 [TBL] [Abstract][Full Text] [Related]
32. Monomerization as a prerequisite for intramolecular cleavage and shedding of the thyrotropin receptor. Latif R; Ando T; Davies TF Endocrinology; 2004 Dec; 145(12):5580-8. PubMed ID: 15319351 [TBL] [Abstract][Full Text] [Related]
33. Thyrotropin (TSH) receptor autoantibodies do not appear to bind to the TSH receptor produced in an in vitro transcription/translation system. Prentice L; Sanders JF; Perez M; Kato R; Sawicka J; Oda Y; Jaskolski D; Furmaniak J; Smith BR J Clin Endocrinol Metab; 1997 Apr; 82(4):1288-92. PubMed ID: 9100609 [TBL] [Abstract][Full Text] [Related]
34. Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Evans M; Sanders J; Tagami T; Sanders P; Young S; Roberts E; Wilmot J; Hu X; Kabelis K; Clark J; Holl S; Richards T; Collyer A; Furmaniak J; Smith BR Clin Endocrinol (Oxf); 2010 Sep; 73(3):404-12. PubMed ID: 20550534 [TBL] [Abstract][Full Text] [Related]
35. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor. Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630 [TBL] [Abstract][Full Text] [Related]
36. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs. Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493 [TBL] [Abstract][Full Text] [Related]
37. Exosomes Expressing Thyrotropin Receptor Attenuate Autoantibody-Mediated Stimulation of Cyclic Adenosine Monophosphate Production. Edo N; Kawakami K; Fujita Y; Morita K; Uno K; Tsukamoto K; Onose H; Ishikawa T; Ito M Thyroid; 2019 Jul; 29(7):1012-1017. PubMed ID: 31062662 [No Abstract] [Full Text] [Related]
38. Mechanisms of Action of TSHR Autoantibodies. Furmaniak J; Sanders J; Núñez Miguel R; Rees Smith B Horm Metab Res; 2015 Sep; 47(10):735-52. PubMed ID: 26361260 [TBL] [Abstract][Full Text] [Related]
39. Reactivity of thyrotropin receptor autoantibodies with the thyrotropin receptor on western blots. Maruyama M; Sanders J; Oda Y; Kiddie A; Furmaniak J; Rees Smith B Thyroid; 2001 Mar; 11(3):211-9. PubMed ID: 11327611 [TBL] [Abstract][Full Text] [Related]
40. Thyrotropin Receptor Antagonism by a Novel Small Molecule: Preclinical Kahaly GJ; Steiner L; van der Lee MMC; van Achterberg TAE; Arends RJ; Karstens WFJ; Weirauch T; Henseling J; Frommer L; Wolf J; George A Thyroid; 2023 Jun; 33(6):732-742. PubMed ID: 37016815 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]